NCT05675410 2026-04-22
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
National Cancer Institute (NCI)
Phase 3 Recruiting
Clinical Trials
12 trialsNCT03811015 2026-04-13
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT04214262 2026-04-13
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT05976763 2026-04-07
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT04293562 2026-02-24
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Children's Oncology Group
Phase 3 Recruiting
NCT06125028 2025-09-05
LYMFOR
Pentixapharm AG
Phase 3 Terminated
NCT06416852 2024-05-16
Clinical Study of 18F-Alfatide Injection PET/CT
Yantai LNC Biotechnology Singapore PTE. LTD.
Phase 3 Not yet recruiting
NCT00433459 2020-03-26
Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma
Martin-Luther-Universität Halle-Wittenberg
Phase 3 Completed
NCT02938546 2016-10-21
18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study
Shanghai Chest Hospital
Phase 3 Unknown
NCT02074202 2014-02-28
To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma
National Taiwan University Hospital
Phase 3 Unknown
NCT01180751 2013-08-15
18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology
University of Manitoba
Phase 3 Unknown
NCT00522639 2009-06-30
FDG-PET lung
Maastricht Radiation Oncology
Phase 3 Terminated